Ascom Holding AG (SWX:ASCN)
Switzerland · Delayed Price · Currency is CHF 5.17
+0.09 (1.77%)
Mar 12, 2026, 5:30 PM CET
Ascom Holding AG Revenue
In the year 2025, Ascom Holding AG had annual revenue of 292.10M CHF with 1.88% growth. Ascom Holding AG had revenue of 152.10M in the half year ending December 31, 2025, with 3.40% growth.
Revenue
292.10M
Revenue Growth
+1.88%
P/S Ratio
0.62
Revenue / Employee
213.21K
Employees
1,370
Market Cap
182.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 292.10M | 5.40M | 1.88% |
| Dec 31, 2024 | 286.70M | -10.60M | -3.57% |
| Dec 31, 2023 | 297.30M | -100.00K | -0.03% |
| Dec 31, 2022 | 297.40M | 5.90M | 2.02% |
| Dec 31, 2021 | 291.50M | 10.50M | 3.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.36B |
| Novartis AG | 44.94B |
| Lonza Group AG | 6.53B |
| Galderma Group AG | 4.16B |
| DocMorris AG | 1.06B |
| COLTENE Holding AG | 240.57M |
| IVF Hartmann Holding AG | 159.69M |
| Santhera Pharmaceuticals Holding AG | 49.02M |